Medical Cannabis Market to be Worth ~US$ 53 billion by 2027

Medical Cannabis Market Segmentation by Derivative:
Cannabidiol, Tetrahydrocannabinol, and Others; Application:
Mental Health Management, Neurological Disorders
Management, and Pain Management; Route of
Administration: Nasal, Oral, and Others; and Distribution
Channel: Hospital Pharmacies, Retail Pharmacies, and Online
Pharmacies, and Forecast, 2019 - 2027
©2019 Transparency Market Research, All Rights Reserved

Sr. No.
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Chapter 8
Chapter 9
Chapter 10
Chapter 11
Chapter 12
Chapter 13
Chapter 14
Chapter 15
Content
Preface
Assumptions and Research Methodology
Market Overview
Market Dynamics
Global Medical Cannabis Market Analysis and Forecasts, By Software Type
Global Medical Cannabis Market Analysis, by Modality
Global Medical Cannabis Market Analysis, by Application
Global Medical Cannabis Market Analysis, by End-user
Global Medical Cannabis Market Analysis and Forecast by Region
North America Medical Cannabis Market Analysis and Forecast
Europe Medical Cannabis Market Analysis and Forecast
Asia Pacific Medical Cannabis Market Analysis and Forecast
Latin America Medical Cannabis Market Analysis and Forecast
Middle East & Africa Medical Cannabis Market Analysis and Forecast
Competition Landscape
©2019 Transparency Market Research, All Rights Reserved

According to the latest report published by Transparency Market Research on the
global medical cannabis market for the historical period 2017–2018 and forecast
period from 2019 to 2027.
Higher demand for pain management products is projected to be a major driver of
the global medical cannabis market during the forecast period
The benefit of medical cannabis is that it complements the normal cannabis system
called the endocannabinoid system in the body.
Interest in and usage of medical cannabis is increasing significantly in several
countries.
©2019 Transparency Market Research, All Rights Reserved

The global medical cannabis market was valued at US$ 8 Bn in 2018 and is
anticipated to expand at a CAGR of ~27% from 2019 to 2027
Regulations governing its usage differ across countries and influence medical
practice and experience.
The current opinion among the public is that medical cannabis has the therapeutic
potential to prevent and treat a long list of disorders.
Cannabis therapy provides the geriatric population with relief from symptoms such
as vomiting, sleep difficulties, chronic pain, tremor, agitation, spasticity, nausea,
and decreased appetite.

Product invention and advancements in cannabis varieties, infused products,
concentrates, vaporizing technology, and cannabis-based pharmaceutical products
are projected to drive consumer adoption and spending.
Medical cannabis consumer product companies will seek to differentiate their
products through marketing, pricing, packaging, distribution, selection, and quality.
In terms of derivative, the global medical cannabis market has been classified into
cannabidiol (CBD), tetrahydrocannabinol (THC), and others.
©2019 Transparency Market Research, All Rights Reserved

The global medical cannabis market is highly fragmented, with a large number of
players holding majority share in domestic markets.
Development and commercialization of medical cannabis products is one of the key
trends in the global medical cannabis market.
Prominent players operating in the global medical cannabis market include Canopy
Growth Corp., United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald
Health Therapeutics, GW Pharmaceuticals plc, Tilray, Medical Marijuana, Inc., The
Supreme Cannabis Company, Inc., and The Cronos Group.
©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website
www.transparencymarketresearch.com
For sales queries or new topics email us on:
sales@transparencymarketresearch.com
Thank You
©2019 Transparency Market Research, All Rights Reserved